| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:3322-3328.)
© 2004 American Heart Association, Inc.
Molecular Cardiology |
From the Department of Vascular Regeneration (A.H., H.K., N.N.), Graduate School of Medicine, University of Tokyo, Tokyo; the Division of Tissue Engineering (A.H., H.K., N.N., T.T.), University of Tokyo Hospital, Tokyo; the Division of Vascular Surgery (A.H., H.K., T.M., H.S., H.N.), Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo; and the Institute for Frontier Medical Sciences (T.K., Y.T.), Kyoto University, Kyoto, Japan.
Correspondence to Hiroyuki Koyama, MD, Department of Vascular Regeneration, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail hkoyama-tky{at}umin.ac.jp
Received June 28, 2004; revision received August 17, 2004; accepted August 26, 2004.
Background Various growth factors promote collateral vessel development and are regarded as promising for the treatment of vascular occlusive diseases. However, an efficacious delivery system for them has yet to be established. We devised a strategy to augment functional collateral vessels by using acidic gelatin hydrogel microspheres (AGHMs) incorporating basic fibroblast growth factor (bFGF). The aim of the present study was to investigate the hypothesis that by intra-arterial (IA) administration of bFGF-impregnated AGHMs, bFGF could be delivered from AGHMs trapped in distal small-diameter vessels and thereby induce functional collateral vessels with an assured blood supply through the process of arteriogenesis.
Methods and Results Various sizes of AGHMs (3 mg) incorporating 125I-labeled bFGF were injected into the left internal iliac artery of a rabbit model of hindlimb ischemia. Less than 50% of radioactivity accumulated in the ischemic hindlimb after injection of AGHMs that were 10 µm in diameter, whereas
80% of radioactivity was counted in the ischemic limb after administration of 29- or 59-µm-diameter AGHMs. Calf blood pressure ratio and the ratio of regional blood flow of the bilateral hindlimbs immediately before and after IA administration of 29-µmdiameter AGHMs showed no significant change. Then we evaluated the function of the developed collateral vessels 28 days after IA administration of bFGF-impregnated, 29-µm-diameter AGHMs. IA administration of bFGF-impregnated AGHMs induced marked collateral vessel improvement compared with IA administration of phosphate buffered salinetreated AGHMs and intramuscular administration of bFGF-impregnated AGHMs.
Conclusions IA administration of bFGF-impregnated, 29-µm-diameter AGHMs strongly induced functional collateral vessels without worsening ischemia, indicating the possible therapeutic usefulness of this approach.
Key Words: angiogenesis collateral circulation growth substances ischemia microspheres
This article has been cited by other articles:
![]() |
A. Seko, N. Nitta, A. Sonoda, S. Ohta, M. Takahashi, K. Murata, and Y. Tabata Vascular Regeneration by Repeated Infusions of Basic Fibroblast Growth Factor in a Rabbit Model of Hind-Limb Ischemia Am. J. Roentgenol., June 1, 2009; 192(6): W306 - W310. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakai, N. Kuno, F. Takamatsu, E. Kimura, H. Kohno, K. Okano, and K. Kitahara Prolonged Protective Effect of Basic Fibroblast Growth Factor-Impregnated Nanoparticles in Royal College of Surgeons Rats Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3381 - 3387. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |